- Net sales of $947 million were flat year-over-year, organic sales decreased (0.3%)
- GAAP gross margin of 52.2%, GAAP net loss of ($266) million or ($1.25) per share
- Adjusted EBITDA margin of 18.2%, adjusted EPS of $0.49
- Revised FY23 outlook: organic sales growth of ~1% (from ~3%); adjusted EPS of $1.80 to $1.85 (from $1.92 to $2.02)
- Company expects to repurchase $150 million of its common stock in Q4 2023
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.